Growth Of Cell Signaling Market by Type Cell Signaling Market | Page 2

View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/cell-signaling-market-80206120.html
By pathway, the cell signaling market is segmented into AMP-activated protein kinase (AMPK),
Akt, ErbB/HER, Hedgehog (Hh), NF-êB, Janus kinase and signal transducer and activator of
transcription (JAK/STAT), Notch, and other signaling pathways. The Akt pathway segment is
estimated to account for the largest share of the cell signaling market in 2017.
Based on signaling type, the market is segmented into paracrine, endocrine, autocrine,
juxtacrine, and other signaling types (intracrine and neuronal signaling). The endocrine segment
is estimated to account for the largest share of the cell signaling market in 2017.
On the basis of technology, the cell signaling market is segmented into enzyme-linked
immunosorbent assay (ELISA), immunohistochemistry (IHC), microscopy, flow cytometry,
western blotting, mass spectrometry, and other technologies (immunofluorescence and
immunoprecipitation). The microscopy segment is estimated to account for the largest share in
2017.
Based on application, the market is segmented into research applications (cancer research,
immunology research, stem cells research, and other research applications) and medical
applications. The research applications segment is estimated to account for the largest share of
the cell signaling market in 2017.
Request for Free Sample Report @
https://www.marketsandmarkets.com/pdfdownload.asp?id=80206120
On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest
of the World (RoW). North America is estimated to account for the largest share of the cell
signaling market in 2017. Growth in this regional segment is driven by the growth in geriatric
population, rising incidence of chronic diseases, and improved life science research
infrastructure in the region.
The key players in the cell signaling market include Merck KGaA (Germany), Thermo Fisher
Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a
subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.),
QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.),
Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany), Full Moon
2